Did you see the CEO of Aegerion on CNBC this morni
Post# of 72433
Did you see the CEO of Aegerion on CNBC this morning? They just got their first drug approved for cholesterol for a market of potentially 6000 patients worldwide and expect first year sales of $75 million. They are up 70% in the past few months and trading at $27+.... can you imagine what CTIX will be at with KEVETRIN a success? Your $800+ might be in the ballpark!!!!
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)